iRhythm Technologies, Inc.

Equities

IRTC

US4500561067

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 17:53:07 09/12/2024 GMT 5-day change 1st Jan Change
84.54 USD -0.75% Intraday chart for iRhythm Technologies, Inc. -4.28% -21.39%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
IRhythm Technologies, Inc. Presents at Citi's 2024 Global Healthcare Conference, Dec-04-2024 10:15 AM 12-04
Wells Fargo Downgrades iRhythm Technologies to Equalweight, Price Target is $86 12-03 MT
Integra LifeSciences Holdings Corporation Announces Chief Executive Officer Changes 11-04 CI
Integra LifeSciences Holdings Corporation Announces Executive Changes 11-04 CI
Earnings Flash (IRTC) IRHYTHM Reports Q3 Loss $-1.26 10-30 MT
Earnings Flash (IRTC) IRHYTHM Posts Q3 Revenue $147.5M 10-30 MT
IRhythm Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 10-30 CI
IRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device 10-30 CI
IRhythm Technologies, Inc., Q3 2024 Earnings Call, Oct 30, 2024 10-30
IRhythm Technologies, Inc. Provides Earnings Guidance for the Year 2024 10-30 CI
Truist Raises Price Target on iRhythm Technologies to $95 From $80, Keeps Buy Rating 10-22 MT
IRhythm Gets FDA Clearance for Design Updates Made to Zio AT Device; Shares Rise After-Hours 10-21 MT
IRhythm Technologies, Inc. Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio AT Device 10-21 CI
Truist Cuts Price Target on iRhythm Technologies to $80 From $117, Keeps Buy Rating 10-14 MT
Goldman Sachs Initiates iRhythm Technologies at Neutral With $78 Price Target 10-04 MT
IRhythm Technologies Secures Japanese Approval for EGC Monitoring Device 09-11 MT
IRhythm Technologies, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 03:20 PM 09-04
IRhythm Technologies Signs License Agreement With BioIntelliSense for Multiparameter Sensor Technology 09-04 MT
IRhythm Technologies, Inc. Reaffirms Earnings Guidance for the Year 2024 09-04 CI
IRhythm Technologies, Inc. Announces Results of GUARD-AF Trial 09-01 CI
IRhythm Technologies Commercially Rolls out Zio Monitor, Zio LTCM ECG Service in Four European Countries 08-29 MT
Needham Adjusts iRhythm Technologies' PT to $119 From $138, Keeps Buy Rating 08-02 MT
Truist Adjusts iRhythm Technologies' PT to $117 From $134, Keeps Buy Rating 08-02 MT
Oppenheimer Adjusts iRhythm Technologies Price Target to $145 From $165, Maintains Outperform Rating 08-02 MT
IRhythm Technologies Appoints Daniel Wilson as Finance Chief 08-02 MT
Chart iRhythm Technologies, Inc.
IRTC: Dynamic Chart
Logo iRhythm Technologies, Inc.
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
Employees
2,000
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
surperformance-ratings-light-chart IRHYTHM-TECHNOLOGIES-INCMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
85.18USD
Average target price
97.25USD
Spread / Average Target
+14.17%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. IRTC Stock
  4. News iRhythm Technologies, Inc.
  5. Irhythm Technologies Insider Sold Shares Worth $360,983, According to a Recent SEC Filing